Latest news

Stay up to date

Receive updates on new technology developments, market and industry trends, special events, Mayo Clinic technologies available for licensing, and more.

BioSpace | September 20, 2022

EXCERPT:  MoatBio holds an exclusive patent license from Mayo Clinic for the novel second generation single-cycle adenovirus vaccine platform (SC-AdVax) to develop intranasal and oral vaccines that can elicit and boost both mucosal and systemic immunity for the treatment of infectious diseases, like COVID-19. 

Twin Cities Business | September 1, 2022

EXCERPT: Mayo Clinic Ventures chair Andrew Danielsen estimated that the accelerator will give birth to about one to three new companies a year.

Mass Device | August 1, 2022

EXCERPT: Mayo Clinic participated, making the Israel-based firm a Mayo Clinic portfolio company.

Med City News | July 15, 2022

EXCERPT: Anumana was formed by Mayo Clinic and nference, a company that uses unstructured electronic medical records data from medical centers to develop new diagnostics and treatments.

Mass Devices  | May 24, 2022

EXCERPT: The algorithm is Anumana’s second to receive a breakthrough nod, with its low ejection fraction algorithm (developed by Mayo Clinic and licensed by Anumana) garnering approval in 2019, plus FDA emergency use authorization (EUA) for COVID-19 in 2020.

Star Tribune  | May 17, 2022

EXCERPT: The company, an outgrowth of Mayo Clinic, recently raised more money from investors as it seeks new ways to treat cancer

Mayo Clinic News Network | May 2, 2022

EXCERPT: Single-lead ECG tracings from an Apple Watch interpreted by an artificial intelligence (AI) algorithm developed at Mayo Clinic effectively identified patients with a weak heart pump.

1 4 5 6 7 8